Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 162

The DOI matches its Crossref record.

Antioxidative Function of L-FABP in L-FABP Stably Transfected Chang Liver Cells *

Wang, Guqi, Gong, Yuewen, Anderson, Judy, Sun, Dongfeng, Minuk, Gerald, Roberts, Michael S., Burczynski, Frank J. · 2005 · Hepatology

Abstract

Liver fatty acid binding protein (L-FABP) contains amino acids that are known to possess antioxidant function. In this study, we tested the hypothesis that L-FABP may serve as an effective endogenous cytoprotectant against oxidative stress. Chang liver cells were selected as the experimental model because of their undetectable L-FABP mRNA level. Full-length L-FABP cDNA was subcloned into the mammalian expression vector pcDNA3.1 (pcDNA-FABP). Chang cells were stably transfected with pc-DNA-FABP or vector (pcDNA3.1) alone. Oxidative stress was induced by incubating cells with 400 μmol/L H2O2 or by subjecting cells to hypoxia/reoxygenation. Total cellular reactive oxygen species (ROS) was determined using the fluorescent probe DCF. Cellular damage induced by hypoxia/reoxygenation was assayed by lactate dehydrogenase (LDH) release. Expression of L-FABP was documented by regular reverse transcription polymerase chain reaction (RT-PCR), real-time RT-PCR, and Western blot. The pcDNA-FABP–transfected cells expressed full-length L-FABP mRNA, which was absent from vector-transfected control cells. Western blot showed expression of 14-kd L-FABP protein in pcDNA-FABP–transfected cells, but not in vector-transfected cells. Transfected cells showed decreased DCF fluorescence intensity under oxidative stress (H2O2 and hypoxia/reoxygenation) conditions versus control in inverse proportion to the level of L-FABP expression. Lower LDH release was observed in the higher L-FABP–expressed cells in hypoxia/reoxygenation experiments. In conclusion , we successfully transfected and cloned a Chang liver cell line that expressed the L-FABP gene. The L-FABP–expressing cell line had a reduced intracellular ROS level versus control. This finding implies that L-FABP has a significant role in oxidative stress. (Hepatology 2005;42:871–879.)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.20857

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 50

  1. Yamamoto, 1998, Oxidative stress in patients with hepatitis, cirrhosis, and hepatoma evaluated by plasma antioxidants., Biochem Biophys Res Commun, 247, 166, 10.1006/bbrc.1998.8752 · DOI
  2. Bordewick, 1989, Compartmentation of hepatic fattyacidbinding protein in liver cells and its effect on microsomal phosphatidic acid biosynthesis., Biol Chem Hoppe Seyler, 370, 229, 10.1515/bchm3.1989.370.1.229 · DOI
  3. Fahimi, 1990, Localization of the hemebinding protein in the cytoplasm and of a hemebinding proteinlike immunoreactive protein in the nucleus of rat liver parenchymal cells: immunocytochemical evidence of the subcellular distribution corroborated by radioimmunoassay and immunoblotting., Hepatology, 11, 859, 10.1002/hep.1840110522 · doi:10.1002/hep.1840110522
  4. EkVon Mentzer, 2001, Binding of 13hode and 15hete to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. implications for transmembrane and intracellular transport and for protection from lipid peroxidation., J Biol Chem, 276, 15575, 10.1074/jbc.M011623200 · doi:10.1074/jbc.m011623200
  5. Raza, 1989, Specific high affinity binding of lipoxygenase metabolites of arachidonic acid by liver fatty acid binding protein., Biochem Biophys Res Commun, 161, 448, 10.1016/0006-291X(89)92619-3 · DOI
  6. Burnett, 1979, Utilization of long chain fatty acids by rat liver: studies of the role of fatty acid binding protein., Gastroenterology, 77, 241, 10.1016/0016-5085(79)90272-5 · DOI
  7. Thompson, 1999, Liver fatty acid binding protein: species variation and the accommodation of different ligands., Biochim Biophys Acta, 1441, 117, 10.1016/S1388-1981(99)00146-8 · DOI
  8. Bassuk, 1987, Liver fatty acid binding protein is the mitosisassociated polypeptide target of a carcinogen in rat hepatocytes. Proc.Natl.Acad., Sci U S A, 84, 7547, 10.1073/pnas.84.21.7547 · DOI
  9. Wang, 2004, Enhanced expression of cytosolic fatty acid binding protein and fatty acid uptake during liver regeneration in rats., Mol Cell Biochem, 262, 41, 10.1023/B:MCBI.0000038214.52184.82 · doi:10.1023/b:mcbi.0000038214.52184.82
  10. Hasinoff, 2002, Dexrazoxane (ICRF187) protects cardiac myocytes against hypoxiareoxygenation damage., Cardiovasc Toxicol, 2, 111, 10.1385/CT:2:2:111 · DOI
  11. Wang, 2002, Infection of myocytes with chlamydiae., Microbiology, 148, 3955, 10.1099/00221287-148-12-3955 · doi:10.1099/00221287-148-12-3955
  12. Subramaniam, 2002, Cellular oxidant stress and advanced glycation endproducts of albumin: caveats of the dichlorofluorescein assay., Arch Biochem Biophys, 400, 15, 10.1006/abbi.2002.2776 · DOI
  13. Jaeschke, 2003, Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning., Am J Physiol Gastrointest Liver Physiol, 284, G15, 10.1152/ajpgi.00342.2002 · DOI · Paper page
  14. Glatz, 1996, Cellular fatty acidbinding proteins: their function and physiological significance., Prog Lipid Res, 35, 243, 10.1016/S0163-7827(96)00006-9 · DOI · Paper page
  15. Atshaves, 2002, Expression of fatty acid binding proteins inhibits lipid accumulation and alters toxicity in L cell fibroblasts., Am J Physiol Cell Physiol, 283, C688, 10.1152/ajpcell.00586.2001 · DOI
  16. Huang, 2004, Liver fatty acidbinding protein colocalizes with peroxisome proliferator activated receptor alpha and enhances ligand distribution to nuclei of living cells., Biochemistry, 43, 2484, 10.1021/bi0352318 · DOI
  17. Sinha, 1999, Increased expression of epidermal fatty acid binding protein, cofilin, and 1433sigma (stratifin) detected by twodimensional gel electrophoresis, mass spectrometry and microsequencing of drugresistant human adenocarcinoma of the pancreas., Electrophoresis, 20, 2952, 10.1002/(SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H · doi:10.1002/(sici)1522-2683(19991001)20:14<2952::aid-elps2952>3.0.co;2-h
  18. Guajardo, 2002, Retinal fatty acid binding protein reduce lipid peroxidation stimulated by longchain fatty acid hydroperoxides on rod outer segments., Biochim Biophys Acta, 1581, 65, 10.1016/S1388-1981(02)00121-X · DOI
  19. Ek, 1997, Fatty acid binding proteins reduce 15lipoxygenaseinduced oxygenation of linoleic acid and arachidonic acid., Biochim Biophys Acta, 1346, 75, 10.1016/S0005-2760(97)00021-0 · DOI
  20. Catala, 1995, Inhibition of microsomal chemiluminescence by cytosolic fractions containing fatty acid binding protein., Arch Physiol Biochem, 103, 39, 10.3109/13813459509007561 · doi:10.3109/13813459509007561
  21. Samanta, 1989, Free radical scavenging by myocardial fatty acid binding protein., Free Radic Res Commun, 7, 73, 10.3109/10715768909087926 · doi:10.3109/10715768909087926
  22. Zimmerman, 2001, Fattyacidbinding proteins do not protect against induced cytotoxicity in a kidney cell model., Biochem J, 360, 159, 10.1042/bj3600159 · DOI
  23. Halliwell, 1999, Antioxidant defense mechanisms: from the beginning to the end (of the beginning)., Free Radic Res, 31, 261, 10.1080/10715769900300841 · DOI · Paper page
  24. Csonka, 2000, Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts., Free Radic Biol Med, 29, 612, 10.1016/S0891-5849(00)00365-8 · DOI
  25. Khynriam, 2002, Changes in glutathionerelated enzymes in tumorbearing mice after cisplatin treatment., Cell Biol Toxicol, 18, 349, 10.1023/A:1020899221192 · doi:10.1023/a:1020899221192
  26. Matsumaru, 2003, Mechanisms for sensitization to TNFinduced apoptosis by acute glutathione depletion in murine hepatocytes., Hepatology, 37, 1425, 10.1053/jhep.2003.50230 · DOI
  27. Okuyama, 2003, Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice., Hepatology, 37, 1015, 10.1053/jhep.2003.50203 · DOI
  28. Moskovitz, 1996, Chromosomal localization of the mammalian peptidemethionine sulfoxide reductase gene and its differential expression in various tissues., Proc Natl Acad Sci U S A, 93, 3205, 10.1073/pnas.93.8.3205 · DOI
  29. Levine, 1999, Methionine residues may protect proteins from critical oxidative damage., Mech Ageing Dev, 107, 323, 10.1016/S0047-6374(98)00152-3 · DOI · Paper page
  30. Moskovitz, 1999, Methionine sulfoxide reductase in antioxidant defense., Methods Enzymol, 300, 239, 10.1016/S0076-6879(99)00130-5 · DOI
  31. Levine, 1996, Methionine residues as endogenous antioxidants in proteins., Proc Natl Acad Sci U S A, 93, 15036, 10.1073/pnas.93.26.15036 · DOI · Paper page
  32. Stadtman, 2004, Cyclic oxidation and reduction of methionine residues of proteins in antioxidant defense and cellular regulation., Arch Biochem Biophys, 423, 2, 10.1016/j.abb.2003.10.001 · DOI
  33. Thomas, 1995, Protein sulfhydryls and their role in the antioxidant function of protein Sthiolation., Arch Biochem Biophys, 319, 1, 10.1006/abbi.1995.1261 · DOI · Paper page
  34. Sato, 1996, Rat liver fatty acidbinding protein: identification of a molecular species having a mixed disulfide with cysteine at cysteine69 and enhanced protease susceptibility., J Biochem, 120, 908, 10.1093/oxfordjournals.jbchem.a021505 · DOI
  35. Bernlohr, 1997, Intracellular lipidbinding proteins and their genes., Annu Rev Nutr, 17, 277, 10.1146/annurev.nutr.17.1.277 · DOI · Paper page
  36. Bentley, 1993, Hepatic peroxisome proliferation in rodents and its significance for humans., Food Chem Toxicol, 31, 857, 10.1016/0278-6915(93)90225-N · DOI · Paper page
  37. Goel, 1986, Peroxisome proliferation and lipid peroxidation in rat liver., Cancer Res, 46, 1324
  38. Tamura, 1990, Longterm effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats., Carcinogenesis, 11, 445, 10.1093/carcin/11.3.445 · doi:10.1093/carcin/11.3.445
  39. Reddy, 1989, Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis., Mutat Res, 214, 63, 10.1016/0027-5107(89)90198-X · DOI · Paper page
  40. Tomaszewski, 1986, In vitro steadystate levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators., Carcinogenesis, 7, 1871, 10.1093/carcin/7.11.1871 · doi:10.1093/carcin/7.11.1871
  41. Perera, 1986, Suppression of cholinedeficient dietinduced hepatocyte membrane lipid peroxidation in rats by the peroxisome proliferators 4chloro6(2,3xylidino)2pyrimidinylthio(Nbetahydroxyethyl) acetamide and di(2ethylhexyl)phthalate., Cancer Res, 46, 3304
  42. Elliott, 1987, Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisomal proliferators., Carcinogenesis, 8, 1213, 10.1093/carcin/8.9.1213 · DOI
  43. Handler, 1992, Induction of peroxisomes by treatment with perfluorooctanoate does not increase rates of H2O2 production in intact liver., Toxicol Lett, 60, 61, 10.1016/0378-4274(92)90047-N · DOI
  44. Conway, 1995, Effect of the hepatocarcinogenic peroxisome proliferator Wy14,643 in vivo: no increase in ethane exhalation or hepatic conjugated dienes., Toxicol Appl Pharmacol, 135, 229, 10.1006/taap.1995.1228 · doi:10.1006/taap.1995.1228
  45. Garberg, 1992, Peroxisome proliferation and resistance to hydrogen peroxide in rat hepatocytes: is development of resistance an adaptation to cytotoxicity?, Carcinogenesis, 13, 1751, 10.1093/carcin/13.10.1751 · doi:10.1093/carcin/13.10.1751
  46. Deplanque, 2004, Cell protection through PPAR nuclear receptor activation.., Therapie, 59, 25, 10.2515/therapie:2004006 · DOI
  47. Tuchweber, 1978, Prevention of CeCl3induced hepatotoxicity by hypolipidemic compounds., Arch Toxicol, 41, 223, 10.1007/BF00354094 · doi:10.1007/bf00354094
  48. Chen, 2002, Protection against acetaminophen hepatotoxicity by clofibrate pretreatment: role of catalase induction., J Biochem Mol Toxicol, 16, 227, 10.1002/jbt.10043 · doi:10.1002/jbt.10043
  49. NichollsGrzemski, 2000, Clofibrateinduced in vitro hepatoprotection against acetaminophen is not due to altered glutathione homeostasis., Toxicol Sci, 56, 220, 10.1093/toxsci/56.1.220 · DOI
  50. NichollsGrzemski, 2000, Clofibrate pretreatment in mice confers resistance against hepatic lipid peroxidation., J Biochem Mol Toxicol, 14, 335, 10.1002/1099-0461(2000)14:6<335::AID-JBT6>3.0.CO;2-O · DOI

Cited by

See all 162

Metadata

Authors
Wang, G., Gong, Y., Anderson, J., Sun, D., Minuk, G., Roberts, M. S., & Burczynski, F. J.
Venue
Hepatology
Published
2005-10
Volume
42
Issue
4
Pages
871-879
ISSN
0270-9139 (ISSN-L)
OpenAlex
W1967618979
Cited by
162
References
0
FWCI
3.47
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 3622 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antioxidative Function of L-FABP in L-FABP Stably Transfected Chang Liver Cells *. https://app.cochat.ai/papers/10.1002/hep.20857
The paper
Wang, G., Gong, Y., Anderson, J., Sun, D., Minuk, G., Roberts, M. S., & Burczynski, F. J. (2005). Antioxidative Function of L-FABP in L-FABP Stably Transfected Chang Liver Cells *. Hepatology. https://doi.org/10.1002/hep.20857

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.